Genomed Spólka Akcyjna (WSE:GEN)
Poland · Delayed Price · Currency is PLN 33.00
-0.20 (-0.60%)
At close: Sep 4, 2026
Genomed Spólka Akcyjna Balance Sheet
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 7.33 | 6.1 | 5.24 | 5.26 | 3.49 | 4.86 |
Cash & Short-Term Investments | 7.33 | 6.1 | 5.24 | 5.26 | 3.49 | 4.86 |
Cash Growth | - | 16.37% | -0.37% | 50.81% | -28.21% | 9.86% |
Accounts Receivable | 2.22 | 2.83 | 1.53 | 1.72 | 1.3 | 1.12 |
Other Receivables | 0.35 | 0.64 | 0.28 | 0.42 | 0.4 | 0.31 |
Receivables | 2.57 | 3.47 | 1.81 | 2.15 | 1.7 | 1.43 |
Inventory | 2.02 | 2.04 | 2.14 | 2.02 | 2.07 | 1.24 |
Restricted Cash | - | - | - | - | - | 0.06 |
Total Current Assets | 11.92 | 11.61 | 9.19 | 9.42 | 7.26 | 7.59 |
Property, Plant & Equipment | 2.53 | 2.84 | 2.13 | 1.2 | 1.7 | 2.17 |
Long-Term Investments | - | - | - | 0.01 | 0.04 | - |
Other Intangible Assets | 0.05 | 0.06 | 0.08 | 0.09 | 0.01 | 0.01 |
Long-Term Deferred Tax Assets | 0.09 | 0.09 | 0.17 | 0.12 | 0.1 | 0.03 |
Other Long-Term Assets | 1.68 | 1.93 | 0.82 | 1.27 | 1.27 | 0.53 |
Total Assets | 16.26 | 16.53 | 12.4 | 12.12 | 10.38 | 10.33 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | - | 0.8 | 0.48 | 0.95 | 0.4 | 0.81 |
Accrued Expenses | 0.26 | 0.26 | 0.36 | 0.38 | 0.34 | 0.14 |
Current Income Taxes Payable | - | 1.01 | 0.67 | 0.62 | 0.42 | 0.5 |
Other Current Liabilities | 3.29 | 0.04 | 0.05 | 0.03 | 0.04 | 0.03 |
Total Current Liabilities | 3.55 | 2.12 | 1.56 | 1.97 | 1.2 | 1.48 |
Pension & Post-Retirement Benefits | 0.31 | 0.09 | 0.09 | 0.07 | 0.01 | 0.01 |
Long-Term Deferred Tax Liabilities | 0.03 | 0.03 | 0.03 | 0.01 | 0.01 | 0.01 |
Other Long-Term Liabilities | - | 0.18 | - | 0.01 | 0.02 | 0.04 |
Total Liabilities | 3.88 | 2.41 | 1.68 | 2.06 | 1.24 | 1.53 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 |
Additional Paid-In Capital | 10.21 | 8.7 | 8.7 | 7.78 | 7.44 | 6.98 |
Retained Earnings | 0.41 | 3.4 | 1.11 | 0.93 | 0.34 | 1.24 |
Comprehensive Income & Other | 1.63 | 1.88 | 0.78 | 1.22 | 1.22 | 0.45 |
Shareholders' Equity | 12.38 | 14.12 | 10.72 | 10.06 | 9.13 | 8.8 |
Total Liabilities & Equity | 16.26 | 16.53 | 12.4 | 12.12 | 10.38 | 10.33 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash (Debt) | 7.33 | 6.1 | 5.24 | 5.26 | 3.49 | 4.86 |
Net Cash Growth | - | 16.37% | -0.37% | 50.81% | -28.21% | 34.03% |
Net Cash Per Share | 5.54 | 4.62 | 3.97 | 3.98 | 2.64 | 3.68 |
Filing Date Shares Outstanding | 1.32 | 1.32 | 1.32 | 1.32 | 1.32 | 1.32 |
Total Common Shares Outstanding | 1.32 | 1.32 | 1.32 | 1.32 | 1.32 | 1.32 |
Working Capital | 8.37 | 9.49 | 7.63 | 7.45 | 6.06 | 6.1 |
Book Value Per Share | 9.37 | 10.68 | 8.11 | 7.61 | 6.91 | 6.66 |
Tangible Book Value | 12.33 | 14.06 | 10.64 | 9.97 | 9.13 | 8.78 |
Tangible Book Value Per Share | 9.33 | 10.64 | 8.05 | 7.55 | 6.91 | 6.65 |
Buildings | - | 0.29 | 0.29 | 0.23 | 0.23 | 0.23 |
Machinery | - | 10.24 | 10.15 | 9.24 | 9.04 | 8.91 |
Construction In Progress | - | 0.02 | 0.02 | 0.02 | 0.11 | 0.34 |